Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LV.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 20500514)

Published in Cancer Sci on April 29, 2010

Authors

Yuichi Ito1, Hayao Nakanishi, Yasuhiro Kodera, Takashi Hirai, Akimasa Nakao, Tomoyuki Kato

Author Affiliations

1: Division of Oncological Pathology, Aichi Cancer Center Research Institute, Nagoya, Japan.

Articles by these authors

A two-step method for marking polypectomy sites in the colon and rectum. Gastrointest Endosc (2003) 3.63

Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer (2006) 3.06

Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery (2013) 2.43

Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas (2004) 2.30

Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer (2011) 2.18

Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a critical reappraisal from the viewpoint of lymph node retrieval. J Am Coll Surg (2004) 2.18

Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer. World J Surg (2008) 2.15

Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer (2012) 2.09

Myocardial velocity gradient as a noninvasively determined index of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (2003) 2.05

Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery (2006) 1.96

Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum (2006) 1.74

Height, weight, menstrual and reproductive factors and risk of gastric cancer among Japanese postmenopausal women: analysis by subsite and histologic subtype. Int J Cancer (2002) 1.74

Middle pancreatectomy: safety and long-term results. Surgery (2009) 1.69

D3 Lymph Node Dissection in Right Hemicolectomy with a No-touch Isolation Technique in Patients With Colon Cancer. Dis Colon Rectum (2013) 1.64

Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. Hepatology (2006) 1.61

Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum (2003) 1.60

Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. J Hepatol (2004) 1.55

Long term parathyroid function following total parathyroidectomy with autotransplantation in adult patients with MEN2A. Endocr J (2009) 1.54

Sema3A regulates bone-mass accrual through sensory innervations. Nature (2013) 1.53

Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. J Gastroenterol (2004) 1.52

Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas (2011) 1.52

Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum (2003) 1.51

Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation. Transplantation (2011) 1.47

Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin Cancer Res (2002) 1.46

Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat (2002) 1.45

Laparoscopic surgery for gastric cancer: a collective review with meta-analysis of randomized trials. J Am Coll Surg (2010) 1.42

Phase II clinical trial of postoperative S-1 monotherapy for gastric cancer patients with free intraperitoneal cancer cells detected by real-time RT-PCR. World J Surg (2010) 1.41

Enzyme-linked immunosorbent assay for human leukocyte antigen antibody detection and urine protein test recommended for follow-up monitoring after renal transplantation. Transplantation (2008) 1.40

Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer. J Mol Med (Berl) (2003) 1.37

Intersphincteric resection in patients with very low rectal cancer: a review of the Japanese experience. Dis Colon Rectum (2006) 1.34

Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22. World J Surg (2011) 1.33

Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas (2012) 1.31

Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res (2013) 1.29

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Ann Surg Oncol (2009) 1.27

Longterm outcomes of early-stage gastric carcinoma patients treated with laparoscopy-assisted surgery. J Am Coll Surg (2007) 1.26

Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis. Int J Oncol (2009) 1.25

Paclitaxel chemotherapy for the treatment of gastric cancer. Gastric Cancer (2009) 1.22

Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum (2003) 1.22

Single-institute prospective trial of laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma. Gastric Cancer (2011) 1.22

PGP9.5 as a marker for invasive colorectal cancer. Clin Cancer Res (2002) 1.21

Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma: a review of 43 cases. J Am Coll Surg (2003) 1.21

Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol (2003) 1.20

Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma. Mol Carcinog (2011) 1.20

Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann Surg Oncol (2008) 1.19

Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo. Oncogene (2002) 1.19

Cytometrical image analysis for immunohistochemical hormone receptor status in breast carcinomas. Pathol Int (2003) 1.18

Dietary risk factors for colon and rectal cancers: a comparative case-control study. J Epidemiol (2006) 1.16

Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis. Clin Cancer Res (2003) 1.15

Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study. J Gastroenterol (2010) 1.14

The potential of oncolytic virus therapy for pancreatic cancer. Cancer Gene Ther (2005) 1.13

A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703). Gastric Cancer (2010) 1.13

Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann Surg (2012) 1.13

A gene-gene interaction between ALDH2 Glu487Lys and ADH2 His47Arg polymorphisms regarding the risk of colorectal cancer in Japan. Carcinogenesis (2005) 1.12

Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery? Pancreas (2009) 1.11

Five-year follow-up evaluation of surgical treatment for cervical myelopathy caused by ossification of the posterior longitudinal ligament: a prospective comparative study of anterior decompression and fusion with floating method versus laminoplasty. Spine (Phila Pa 1976) (2012) 1.11

Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis. J Hepatol (2002) 1.09

Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43. Brain (2012) 1.09

Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res (2002) 1.09

Characterization of in vitro gutlike organ formed from mouse embryonic stem cells. Am J Physiol Cell Physiol (2004) 1.09

Negative pressure external drainage of the pancreatic duct in pancreaticoduodenectomy. Hepatogastroenterology (2010) 1.09

Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunol Immunother (2006) 1.09

Oncological problems in pancreatic cancer surgery. World J Gastroenterol (2006) 1.08

One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogenesis (2005) 1.08

Preservation of the pyloric ring has little value in surgery for pancreatic head cancer: a comparative study comparing three surgical procedures. Ann Surg Oncol (2011) 1.08

Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation? Xenotransplantation (2004) 1.06

A novel function of syndecan-2, suppression of matrix metalloproteinase-2 activation, which causes suppression of metastasis. J Biol Chem (2007) 1.06

Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Liver Int (2005) 1.06

Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters. J Surg Oncol (2008) 1.06

Para-aortic lymph node metastasis in carcinoma of the head of the pancreas. Surgery (2005) 1.06

Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity. Cancer Sci (2008) 1.05

Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β. Cancer Lett (2011) 1.05

Amylase concentration of the drainage fluid as a risk factor for intra-abdominal abscess following gastrectomy for gastric cancer. World J Surg (2010) 1.04

Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2013) 1.04

NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol (2002) 1.04

A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. Cancer Res (2006) 1.04

Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. Oncogene (2002) 1.04

Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer (2014) 1.03

Diverting stoma in rectal cancer surgery. A retrospective study of 329 patients from Japanese cancer centers. Int J Colorectal Dis (2010) 1.02

Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS-45): a nationwide multi-institutional study. Gastric Cancer (2014) 1.02